GF12550935
Bismuth
foil, light tested, 50x50mm, thickness 0.015mm, permanent polyester support, 99.97%
Synonym(s):
Bismuth, BI000140
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
Empirical Formula (Hill Notation):
Bi
CAS Number:
Molecular Weight:
208.98
MDL number:
UNSPSC Code:
12141706
PubChem Substance ID:
NACRES:
NA.23
vapor pressure
<0.1 mmHg ( 20 °C)
Assay
99.97%
form
foil
manufacturer/tradename
Goodfellow 125-509-35
resistivity
129 μΩ-cm, 20°C
size × thickness
50 x 50 mm × 0.015 mm
bp
1560 °C (lit.)
mp
271 °C (lit.)
density
9.8 g/mL at 25 °C (lit.)
SMILES string
[Bi]
InChI
1S/Bi
InChI key
JCXGWMGPZLAOME-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
General description
For updated SDS information please visit www.goodfellow.com.
Legal Information
Product of Goodfellow
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Alexander C Ford et al.
World journal of gastroenterology, 14(48), 7361-7370 (2008-12-26)
To assess the safety of bismuth used in Helicobacter pylori (H pylori) eradication therapy regimens. We conducted a systematic review and meta-analysis. MEDLINE and EMBASE were searched (up to October 2007) to identify randomised controlled trials comparing bismuth with placebo
Hongyan Li et al.
Current opinion in chemical biology, 16(1-2), 74-83 (2012-02-11)
Bismuth has been used in medicine for over two centuries for the treatment of various diseases, in particular for gastrointestinal disorders, owing to its antimicrobial activity. Recent structural characterization of bismuth drugs provides an insight into assembly and pharmacokinetic pathway
Javier P Gisbert et al.
Helicobacter, 10(3), 157-171 (2005-05-21)
To systematically review the Helicobacter pylori eradication efficacy with ranitidine bismuth citrate (RBC) and two antibiotics, and to conduct a meta-analysis of randomized clinical trials comparing the efficacy of proton pump inhibitor (PPI) vs. RBC with two antibiotics for 1
Emma Aneheim et al.
Scientific reports, 5, 12025-12025 (2015-07-15)
To facilitate multicentre clinical studies on targeted alpha therapy, it is necessary to develop an automated, on-site procedure for conjugating rare, short-lived, alpha-emitting radionuclides to biomolecules. Astatine-211 is one of the few alpha-emitting nuclides with appropriate chemical and physical properties
Bismuth in medicine.
Hongzhe Sun et al.
Metal ions in biological systems, 41, 333-378 (2004-06-23)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service